SCHEMBL24916320

SCHEMBL24916320

CCc1cc2c(Br)ccnc2c(OC)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.33
HIPK2 Q9H2X6 1/20 0.33
HTR1A P08908 2/20 0.33
ADRA1D P25100 2/20 0.33
ADRA1A P35348 2/20 0.33
ADRA1B P35368 2/20 0.33
MBOAT4 Q96T53 1/20 0.32
NSD2 O96028 2/20 0.32
CASP6 P55212 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
HPGD P15428 1/20 0.31
MAP4K4 O95819 1/20 0.31
APAF1 O14727 1/20 0.31
TDP2 O95551 1/20 0.31
CASP3 P42574 1/20 0.31
PPP1CA P62136 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
SAE1 Q9UBE0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29923740 1.00 CSNK2A1 (0.33) CSNK2A1HIPK2HTR1AADRA1DADRA1A
SCHEMBL27167395 0.82 PDE10A (0.34) HTR1AADRA1DADRA1AADRA1BSMN1; SMN2
SCHEMBL27167385 0.80 CSNK2A1 (0.35) CSNK2A1HIPK2NSD2CASP6SMN1; SMN2
SCHEMBL24916023 0.80 BCL2L11 (0.33) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL25130855 0.79 CSNK2A1 (0.34) CSNK2A1HIPK2NSD2CASP6SMN1; SMN2
SCHEMBL27167379 0.78 CRHR1 (0.33) MBOAT4NOS3NOS2KDM4EHTT
SCHEMBL30054192 0.78 CRHR1 (0.33) MBOAT4NOS3NOS2KDM4EHTT
SCHEMBL29923376 0.74 PDE10A (0.41) SMN1; SMN2KDM4EMEN1TP53HSP90AA1
SCHEMBL30056847 0.73 CDC7 (0.41) SMN1; SMN2KDM4EKMT2A
SCHEMBL27167368 0.73 CDC7 (0.41) SMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262822-A1 WDR5 INHIBITORS AND MODULATORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-08-08 US disclosed
EP-4055013-B1 WDR5 INHIBITORS AND MODULATORS UNIV VANDERBILT (US) 2024-03-20 EP disclosed
EP-4334305-A1 WDR5 INHIBITORS AND MODULATORS Vanderbilt University (US) 2024-03-13 EP disclosed
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240262822-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 CSNK2A1 975/4885HIPK2 84/4885HTR1A 3972/4885
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 CSNK2A1 933/4885HIPK2 92/4885HTR1A 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.